Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance.
- NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_assertion description "[Taken together with similar recent studies of neuroblastoma- and glioblastoma-derived cells, PI3K inhibition seems to be a more general option to sensitize tumor cells to anthracyclines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance.
- NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_assertion evidence source_evidence_literature NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance.
- NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_assertion SIO_000772 23300809 NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance.
- NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_assertion wasDerivedFrom befree-20140225 NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance.
- NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_assertion wasGeneratedBy ECO_0000203 NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance.
- befree-20140225 importedOn "2014-02-25" NP607258.RARhKP5wVl6mZ2nemPDKPpH0PG6-BK_EPxlsDQgbJlW_M130_provenance.